These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 8835491)

  • 21. Therapeutic strategy in the management of stage II-IV epithelial ovarian carcinoma.
    Sun T; Feng Y; Zhu Y; Zheng Y
    Chin Med J (Engl); 2000 Jul; 113(7):625-7. PubMed ID: 11776033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in the management of epithelial ovarian cancer.
    Berkenblit A; Cannistra SA
    J Reprod Med; 2005 Jun; 50(6):426-38. PubMed ID: 16050567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Secondary cytoreductions in the treatment of ovarian cancers].
    Zylberberg B; Dormont D; Janklewicz S; Daraï E; Madelenat P; Antoine JM
    Gynecol Obstet Fertil; 2000 Feb; 28(2):127-36. PubMed ID: 10758587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Second-look and third-look laparotomies in follow-up of ovarian cancer. A critical review of 6 years' experience].
    Schneider J; Erasun F; Hervas JL; Miñambres JL
    Zentralbl Gynakol; 1987; 109(4):235-42. PubMed ID: 3591059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The results of treatment of epithelial ovarian cancer after centralisation of primary surgery. Results from North Jutland, Denmark.
    Soegaard Andersen E; Knudsen A; Svarrer T; Lund B; Nielsen K; Grove A; Tetsche M
    Gynecol Oncol; 2005 Dec; 99(3):552-6. PubMed ID: 16150480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoadjuvant chemotherapy for unresectable ovarian carcinoma: a French multicenter study.
    Ansquer Y; Leblanc E; Clough K; Morice P; Dauplat J; Mathevet P; Lhommé C; Scherer C; Tigaud JD; Benchaib M; Fourme E; Castaigne D; Querleu D; Dargent D
    Cancer; 2001 Jun; 91(12):2329-34. PubMed ID: 11413522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR).
    Wimberger P; Lehmann N; Kimmig R; Burges A; Meier W; Du Bois A;
    Gynecol Oncol; 2007 Jul; 106(1):69-74. PubMed ID: 17397910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Early debulking surgery after chemotherapy in advanced cancer of the ovary].
    de Gramont A; Pigné A; Louvet C; Sezeur A; Marpeau L; Vaillant JC; Cady J; Varette C; Demuynck B; Couturier JY; Lagadec B; Milliez J; Barrat J; Krulik M
    Ann Chir; 1997; 51(10):1069-76. PubMed ID: 10868028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secondary surgical cytoreduction for advanced epithelial ovarian cancer. Patient selection and review of the literature.
    Bristow RE; Lagasse LD; Karlan BY
    Cancer; 1996 Nov; 78(10):2049-62. PubMed ID: 8918397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prognostic value of early normalization of CA 125 during chemotherapy in stages III and IV ovarian tumors].
    Ferrero JM; Largillier R; Ramaioli A; Heudier P; Teissier E; Namer M
    Bull Cancer; 1997 Jul; 84(7):722-8. PubMed ID: 9339198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Secondary debulking operation in ovarian cancer].
    Jänicke F; Schattenmann G; Kuhn W; Graeff H; Siewert JR
    Chirurg; 1994 Jan; 65(1):10-7. PubMed ID: 8149793
    [No Abstract]   [Full Text] [Related]  

  • 32. Surgery of advanced malignant epithelial tumours of the ovary.
    Favalli G; Odicino F; Pecorelli S
    Forum (Genova); 2000; 10(4):312-20. PubMed ID: 11535982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Radical peritonectomy in 37 patients with stage II and III ovarian cancer].
    Capretti PG; Zeppieri MC; Simonetti A; Rosato S; Lovotti D; Battaini A; Capretti G; Agnes Pradelli B
    Minerva Chir; 2004 Jun; 59(3):233-41. PubMed ID: 15252388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
    Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complete surgical cytoreduction of advanced ovarian carcinoma using the argon beam coagulator.
    Bristow RE; Montz FJ
    Gynecol Oncol; 2001 Oct; 83(1):39-48. PubMed ID: 11585412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study.
    Eisenkop SM; Friedman RL; Wang HJ
    Gynecol Oncol; 1998 May; 69(2):103-8. PubMed ID: 9600815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complete cytoreduction: is epithelial ovarian cancer confined to the pelvis biologically different from bulky abdominal disease?
    Naik R; Nordin A; Cross PA; Hemming D; de Barros Lopes A; Monaghan JM
    Gynecol Oncol; 2000 Aug; 78(2):176-80. PubMed ID: 10926799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrent ovarian carcinoma of low malignant potential: the role of secondary surgical cytoreduction and the prognosis in Chinese patients.
    Zang RY; Yang WT; Shi DR; Xing Y; Cai SM
    J Surg Oncol; 2005 Jul; 91(1):67-72. PubMed ID: 15999350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Follow-up after primary therapy: management of the symptomatic patient-surgery.
    Pecorelli S; Sartori E; Santin A
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S138-42. PubMed ID: 7835798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ovarian cancer from the standpoint of medical oncology].
    Kato Y; Katsumata N
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1017-21. PubMed ID: 17637538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.